This Biotech Stock Has Soared 175%. Here’s Why One Fund Still Sold $3 Million Worth
Key takeaways
- According to an SEC filing dated May 8, 2026, JW Asset Management reduced its holdings in Liquidia by 83,600 shares.
- This was a sale, reducing the stake to 0.25% of JW Asset Management s $243.51 million in reportable U.S. equity assets.
- NASDAQ: ESTA: $173.84 million (71.4% of AUM)
Jonathan Ponciano, The Motley Fool Sat, May 9, 2026 at 11:13 PM GMT+7 4 min read LQDA ESTA COCO CPRX GOOG On May 8, 2026, JW Asset Management reported selling 83,600 shares of Liquidia Corporation (NASDAQ:LQDA), an estimated $3.10 million trade based on quarterly average pricing.
According to an SEC filing dated May 8, 2026, JW Asset Management reduced its holdings in Liquidia by 83,600 shares. The estimated transaction value, calculated using the average closing price for the first quarter of 2026, was $3.10 million. After the trade, the fund reported holding 16,176 shares worth $610,482 at quarter-end. The net position value decreased by $2.83 million over the period.
This was a sale, reducing the stake to 0.25% of JW Asset Management s $243.51 million in reportable U.S. equity assets.